147 related articles for article (PubMed ID: 30700206)
21. Increasing prevalence of papillary thyroid carcinoma in recent years in Greece: the majority are incidental.
Alevizaki M; Papageorgiou G; Rentziou G; Saltiki K; Marafelia P; Loukari E; Koutras DA; Dimopoulos MA
Thyroid; 2009 Jul; 19(7):749-54. PubMed ID: 19534620
[TBL] [Abstract][Full Text] [Related]
22. Occult thyroid carcinoma in our experience -- should we reconsider total thyroidectomy for benign thyroid pathology?
Alecu L; Bărbulescu M; Ursuţ B; Enciu O; Slavu I; Braga V
Chirurgia (Bucur); 2014; 109(2):191-7. PubMed ID: 24742409
[TBL] [Abstract][Full Text] [Related]
23. Retrospective analysis of thyroid nodules by clinical and pathological characteristics, and ultrasonographically detected calcification correlated to thyroid carcinoma in South China.
Chen G; Zhu XQ; Zou X; Yao J; Liang JX; Huang HB; Li LT; Lin LX
Eur Surg Res; 2009; 42(3):137-42. PubMed ID: 19174609
[TBL] [Abstract][Full Text] [Related]
24. Relationship between lymphovascular invasion and clinicopathological features of papillary thyroid carcinoma.
Sezer A; Celik M; Yilmaz Bulbul B; Can N; Tastekin E; Ayturk S; Ustun F; Guldiken S; Sut N
Bosn J Basic Med Sci; 2017 May; 17(2):144-151. PubMed ID: 28284178
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic Factors and Thyroid Nodule Sonographic Features for Predicting Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Retrospective Study of 1204 Patients.
Wang WH; Xu SY; Zhan WW
J Ultrasound Med; 2016 Nov; 35(11):2475-2481. PubMed ID: 27794131
[TBL] [Abstract][Full Text] [Related]
26. Trends in thyroid carcinoma among thyroidectomy patients: a 12-year multicenter study.
Doubi A; Al-Qannass A; Al-Angari SS; Al-Qahtani KH; Alessa M; Al-Dhahri S
Ann Saudi Med; 2019; 39(5):345-349. PubMed ID: 31580696
[TBL] [Abstract][Full Text] [Related]
27. [Non-incidental papillary microcarcinomas of the thyroid].
Monteros Alvi M; Gonorazky S; Virgili E; Soler G; Fernández M; van Cauwlaert L
Medicina (B Aires); 2008; 68(2):139-43. PubMed ID: 18499963
[TBL] [Abstract][Full Text] [Related]
28. [Pathological characteristics of thyroid microcarcinoma. A review of 402 biopsies].
Fardella C; Jiménez M; González H; León A; Goñi I; Cruz F; Solar A; Torres J; Mosso L; González G; Rodríguez JA; Campusano C; López JM; Arteaga E
Rev Med Chil; 2005 Nov; 133(11):1305-10. PubMed ID: 16446853
[TBL] [Abstract][Full Text] [Related]
29. Trends in the clinical characteristics of patients with papillary thyroid carcinoma in Taiwan.
Lin JD; Chao TC; Sun JH; Ho C; Weng HF
Oncology; 2000 May; 58(4):280-5. PubMed ID: 10838492
[TBL] [Abstract][Full Text] [Related]
30. Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experience.
Pelizzo MR; Boschin IM; Toniato A; Pagetta C; Piotto A; Bernante P; Casara D; Pennelli G; Rubello D
Nucl Med Commun; 2004 Jun; 25(6):547-52. PubMed ID: 15167512
[TBL] [Abstract][Full Text] [Related]
31. [Papillary thyroid microcarcinomas: review of 230 cases].
Bozec A; Peyrottes I; Poissonnet G; Chamorey E; Mahdyoun P; Sudaka A; Ettore F; Benisvy D; Bussière F; Marcy PY; Vallicioni J; Demard F; José S; Dassonville O
Rev Laryngol Otol Rhinol (Bord); 2009; 130(4-5):215-20. PubMed ID: 20597400
[TBL] [Abstract][Full Text] [Related]
32. Papillary thyroid microcarcinoma: the significance of high risk features.
Bradley NL; Wiseman SM
BMC Cancer; 2017 Feb; 17(1):142. PubMed ID: 28209140
[TBL] [Abstract][Full Text] [Related]
33. Assessment of risk factors in metastatic/recurrent tall cell variant of papillary thyroid carcinoma.
Okuyucu K; Alagoz E; Ince S; Arslan N
Endokrynol Pol; 2017; 68(6):623-630. PubMed ID: 29022644
[TBL] [Abstract][Full Text] [Related]
34. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
35. Clinical and Pathologic Predictors of Lymph Node Metastasis and Recurrence in Papillary Thyroid Microcarcinoma.
Siddiqui S; White MG; Antic T; Grogan RH; Angelos P; Kaplan EL; Cipriani NA
Thyroid; 2016 Jun; 26(6):807-15. PubMed ID: 27117842
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathological characteristics of thyroid cancer in patients on dialysis for end-stage renal disease.
Demirer AN; Kemal Y; Gursoy A; Sahin M; Tutuncu NB
Thyroid; 2008 Jan; 18(1):45-50. PubMed ID: 18302517
[TBL] [Abstract][Full Text] [Related]
37. Predictors of incomplete response to therapy among Filipino patients with papillary thyroid cancer in a tertiary hospital.
Mendoza ES; Lopez AA; Valdez VA; Cunanan EC; Matawaran BJ; Kho SA; Sero-Gomez MH
J Endocrinol Invest; 2016 Jan; 39(1):55-62. PubMed ID: 26036600
[TBL] [Abstract][Full Text] [Related]
38. New clinical features of thyroid cancer in eastern China.
Xiang J; Wu Y; Li DS; Shen Q; Wang ZY; Sun TQ; An Y; Guan Q
J Visc Surg; 2010 Feb; 147(1):e53-6. PubMed ID: 20587378
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors in papillary microcarcinoma with emphasis on histologic subtyping: a clinicopathologic study of 148 cases.
Ghossein R; Ganly I; Biagini A; Robenshtok E; Rivera M; Tuttle RM
Thyroid; 2014 Feb; 24(2):245-53. PubMed ID: 23745671
[TBL] [Abstract][Full Text] [Related]
40. [The significance of papillary carcinoma of the thyroid for the ENT specialist (author's transl)].
Wey W
HNO; 1979 May; 27(5):150-5. PubMed ID: 457456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
